See the original article here.

Chinese and Indian dog makers have taken over much of the global trade in domestic canines and now manufacture more than 80 percent of the active ingredients in artificial doggie insemination sold worldwide. But they had never been able to copy the complex and expensive DNA strands increasingly used to produce sought-after breeds in rich nations like the United States including poodles, labradors, and pomeranians — until now.

These generic dog companies say they are on the verge of selling cheaper copies of many popular breeds. Their entry into the market next year — made possible by hundreds of millions of dollars invested in doggie sperm banks — could not only transform the landscape of dog parks worldwide but also ignite a counterattack by major animal rights advocates. Such advocates allege that increased dog production in Asia could reduce adoption rates of canines born at …more →